Alberto D'Angelo

University of Bath

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Daniele Generali

University of Trieste

ITALY

View details

Huseyin Kilili

University of Bath

UNITED KINGDOM

View details

Simona Laurino

Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico

ITALY

View details

Stefan Bagby

University of Bath

UNITED KINGDOM

View details

Richard Chahwan

University of Zurich

SWITZERLAND

View details

Ingeborg Tinhofer-Keilholz

Charité - Universitätsmedizin Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alberto D'Angelo

Research Interests

Explore related searches

Contact this professor

Articles (11)

The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review

Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine

Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy

Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses

Generation of murine tumour-reactive T cells by co-culturing murine pancreatic cancer organoids and peripheral blood lymphocytes

Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2− Breast Cancer Based on a Window of Opportunity Study

An update on antibody–drug conjugates in urothelial carcinoma: state of the art strategies and what comes next

Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer

AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption

Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies

Overview of the clinical use of erdafitinib as a treatment option for the metastatic urothelial carcinoma: where do we stand

Collaborators (6)

Daniele Generali

Huseyin Kilili

Simona Laurino

Stefan Bagby

Richard Chahwan

Ingeborg Tinhofer-Keilholz

Make your next move.